Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PSEC vs CGBD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CGBD Captures Overall Composite Edge (51.3 HOLD vs 46.7 HOLD), While PSEC Leads 3–2 on Growth & Valuation Pillars

CGBD Overall Winner 6-Pillar Tally: PSEC 3 – 2 CGBD (1 Tie) Matrix Metrics: PSEC 4 – 6 CGBD

As of Nov 16, 2026, Carlyle Secured Lending, Inc. (CGBD) captures the overall head-to-head institutional edge over Prospect Capital Corporation (PSEC) on higher Unified Composite conviction (51.3/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while PSEC wins 3–2 across the 6-pillar growth and valuation breakdown. PSEC trades at $1.35 (4.2x Forward P/E, 71.1% operating margin) versus CGBD at $10.89 (7.4x Forward P/E, 74.0% operating margin).

  • Growth vs. Quality Trade-Off: CGBD earns the overall head-to-head edge with a stronger Unified Composite Score (51.3/100 HOLD vs. PSEC 46.7/100 HOLD) and 0.43β · 24% Vol risk profile, whereas PSEC leads top-line expansion (-3.7% YoY revenue growth, 1.55x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: PSEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9); meanwhile CGBD is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PSEC vs CGBD
PSEC NASDAQ
Prospect Capital Corporation
Institutional Equity
$1.35
-7.54% 1D
Market Cap $782.6M
TTM Revenue $634M
Forward P/E 4.2x
Beta / 30D Vol 0.84β · 62% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -14.8%), weak momentum, RSI 33
RSI-14: 32.9 · SMA20: $1.49 · SMA50: $1.80
CGBD NASDAQ Head-to-Head Winner
Carlyle Secured Lending, Inc. Common Stock
Institutional Equity
$10.89
-1.71% 1D
Market Cap $750.2M
TTM Revenue $260M
Forward P/E 7.4x
Beta / 30D Vol 0.43β · 24% Vol
Unified Composite Score
51.3 / 100 HOLD
Tech 37.0 Fund 50.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.3%) with fading momentum, RSI 50
RSI-14: 49.8 · SMA20: $10.79 · SMA50: $10.90

6-Pillar Scorecard Institutional Category Breakdown (PSEC 3 – 2 CGBD)

Columns: Metric · PSEC · CGBD
1. Valuation Multiples PSEC
Forward P/E 4.2x 7.4x
Trailing P/E 9.4x 21.6x
PEG Ratio 1.55x 3.54x
EV / Revenue 1.2x 2.9x
2. Growth & Scale PSEC
Revenue Growth (YoY) -3.7% -7.7%
Earnings Growth (YoY) -78.2% -40.5%
TTM Revenue (USD) $634M $260M
Market Cap $782.6M $750.2M
3. Profitability & Quality CGBD
Gross Margin 100.0% 100.0%
Operating Margin 71.1% 74.0%
Net Profit Margin 8.5% 14.3%
Return on Equity (ROE) 1.2% 3.2%
4. Balance Sheet & Cash Flow CGBD
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $5.36 Book/Sh · 1.2% ROE $16.26 Book/Sh · 3.2% ROE
Dividend Yield 34.67% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 26.1% (<1st %ile) 24.9% (65th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat PSEC
OpEx & R&D Intensity 28.9% of Rev ($183M) 26.0% of Rev ($67M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PSEC (4) vs CGBD (6)
Institutional Metric PSEC CGBD Criterion Row Edge
Market Capitalization
Scale
$782.6M $750.2M Larger Scale PSEC
Trailing P/E Ratio
Valuation
9.4x 21.6x Lower Multiple PSEC
Forward P/E Ratio
Valuation
4.2x 7.4x Lower Multiple PSEC
Revenue Growth (YoY)
Growth
-3.7% -7.7% Higher Growth PSEC
Operating Margin (TTM)
Profitability
71.1% 74.0% Higher Margin CGBD
Net Profit Margin
Profitability
8.5% 14.3% Higher Margin CGBD
Return on Equity (ROE)
Capital Efficiency
1.2% 3.2% Higher ROE CGBD
52-Week Range Position
Momentum
3% ($1–$3) 28% ($10–$13) Stronger Trend CGBD
Beta / 30D Volatility
Risk Regime
0.84β · 62% Vol 0.43β · 24% Vol Lower Realized Risk CGBD
Unified Institutional Score
Composite Signal
46.7 / 100 (HOLD) 51.3 / 100 (HOLD) Higher Composite CGBD
Trailing 12M Revenue (USD)
Operating Scale
$634M $260M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.55x PEG · 1.2x EV/Rev 3.54x PEG · 2.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($5.36 Book/Sh · 1.2% ROE) N/A ($16.26 Book/Sh · 3.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CGBD +20.44 pp
PSEC: -15.63% · CGBD: +4.81%
3M Horizon CGBD +37.15 pp
PSEC: -40.0% · CGBD: -2.85%
6M Horizon CGBD +38.09 pp
PSEC: -38.36% · CGBD: -0.27%
1Y Horizon CGBD +42.49 pp
PSEC: -51.44% · CGBD: -8.95%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PSEC vs CGBD. Trailing 12-month operating profitability (PSEC 71.1% vs CGBD 74.0%) and valuation multiples (PSEC 4.2x vs CGBD 7.4x Forward P/E) are benchmarked directly in Pillar 4 below.

PSEC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$634M
Gross Margin100.0%
Op. Margin71.1%
ROE / Fwd P/E1.2% · 4.2x
CGBD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$260M
Gross Margin100.0%
Op. Margin74.0%
ROE / Fwd P/E3.2% · 7.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PSEC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 26.1%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PSEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CGBD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 24.9%
IV Percentile 65th %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CGBD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PSEC Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $782.6M market capitalization and 71.1% operating margin.
OpEx & R&D Reinvestment 28.9% of Rev ($183M)
90D Engineering Disclosures 0 Published
CGBD Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $750.2M market capitalization and 74.0% operating margin.
OpEx & R&D Reinvestment 26.0% of Rev ($67M)
90D Engineering Disclosures 0 Published

Investor FAQ PSEC vs CGBD Key Questions & Quantitative Answers

As of Nov 16, 2026, Carlyle Secured Lending, Inc. (CGBD) captures the overall head-to-head institutional edge over Prospect Capital Corporation (PSEC) on higher Unified Composite conviction (51.3/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while PSEC wins 3–2 across the 6-pillar growth and valuation breakdown. PSEC trades at $1.35 (4.2x Forward P/E, 71.1% operating margin) versus CGBD at $10.89 (7.4x Forward P/E, 74.0% operating margin). Growth vs. Quality Trade-Off: CGBD earns the overall head-to-head edge with a stronger Unified Composite Score (51.3/100 HOLD vs. PSEC 46.7/100 HOLD) and 0.43β · 24% Vol risk profile, whereas PSEC leads top-line expansion (-3.7% YoY revenue growth, 1.55x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: PSEC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9); meanwhile CGBD is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PSEC leads the Growth & Scale pillar: PSEC posts -3.7% YoY revenue growth and -78.2% YoY earnings growth on $634M TTM revenue (100.0% gross margin, 71.1% operating margin), compared with CGBD at -7.7% YoY revenue growth and -40.5% YoY earnings growth on $260M TTM revenue (100.0% gross margin, 74.0% operating margin). On trailing 12-month operating scale, PSEC generates $634M in USD-normalized revenue versus $260M for CGBD. In operating R&D and SG&A reinvestment, PSEC deploys 28.9% of Rev ($183M) (0 90-day corporate R&D disclosures) versus 26.0% of Rev ($67M) (0 disclosures) for CGBD.

PSEC screens cheaper on headline valuation multiples. PSEC trades at 4.2x Forward P/E, 9.4x Trailing P/E, 1.55x PEG, and 1.2x EV/Revenue (unreported cash flow margin), whereas CGBD trades at 7.4x Forward P/E, 21.6x Trailing P/E, 3.54x PEG, and 2.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PSEC (1.2% ROE) versus CGBD (3.2% ROE) capital efficiency.

In options market volatility and institutional positioning, PSEC carries 26.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.84β · 62% Vol realized risk). By comparison, CGBD carries 24.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.43β · 24% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.